Glaucoma

BOSTON – Heru announced the release of re:Vive 2.0, which adds color vision, contrast sensitivity and dark adaptation testing to its wearable diagnostic headset.

BOSTON – Artificial intelligence has enabled machines to accurately predict retinal nerve fiber layer thickness on OCT, Felipe A. Medeiros, MD, PhD, said here at the American Academy of Optometry annual meeting.

Self-tonometry consistently evaluated diurnal IOP fluctuations in patients with ocular hypertension or open-angle glaucoma, according to a crossover clinical treatment trial in Optometry and Vision Science.

Glaucoma may be more likely to develop in glaucoma suspects with a history of anxiety or both anxiety and depression, according to a retrospective cohort study in British Journal of Ophthalmology.

A vital part of glaucoma management is assessing patients for the possibility of progressive disease.

Patients with glaucoma who did not achieve clinician-defined target IOP had more rapid visual field worsening, according to data published in Ophthalmology.

Patients and providers agree that sociobehavioral factors are a key determinant of glaucoma treatment adherence, but they disagree in other areas, according to a study published in Optometry and Vision Science.

The classification of cannabidiol, or CBD, as a food additive may have long-term serious consequences for the visual system. It elevates eye pressure, and we all know sustained elevated IOP results in blindness.

The cornerstone of glaucoma diagnosis and monitoring relies on an assessment of optic nerve structure and function. Advancements in OCT have allowed glaucoma care providers to evaluate optic nerve structure to an unparalleled degree.

NEW YORK — Sustained-release drug delivery for glaucoma treatment offers a way to reduce IOP without relying on surgery or drops and gives physicians a way to customize treatment plans for individual patients, according to a speaker here.